{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:29:24Z","timestamp":1790771364962,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Helicobacter pylori (H. pylori)<\/jats:italic>\n                      infection represents a prevalent global health burden. Current eradication strategies are complicated by increasing antibiotic resistance and detrimental alterations to the gut microbiome. Jinghuaweikang capsule (JWC), a traditional Chinese medicine, has demonstrated efficacy against\n                      <jats:italic>H. pylori<\/jats:italic>\n                      , yet its mechanisms involving microbiota-inflammation interactions remain incompletely elucidated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIM<\/jats:title>\n                    <jats:p>\n                      This study aimed to investigate the effects of the JWC on gastric mucosal\u00a0inflammation and the expression of drug-resistance genes in\n                      <jats:italic>H.\u00a0pylori<\/jats:italic>\n                      -infected mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sixty Kunming mice were randomly allocated into six groups, including normal control group (Control), model group (Model), Western medicine triple group (AC), low-dose JWC group (JWCL), medium-dose JWC group (JWCM), and high-dose JWC group (JWCH). A mouse model of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection was established by intragastric administration of an\n                      <jats:italic>H. pylori<\/jats:italic>\n                      SS1 solution for two weeks. The efficacy of this model was evaluated using rapid urease test (RUT) and Warthin-Starry (WS) silver stain. Subsequently, the experimental cohort of mice underwent pharmacological intervention. Hematoxylin and eosin (HE) staining, enzyme-linked immunosorbent assay (ELISA), and quantitative real-time polymerase chain reaction (qRT-PCR) were used to assess the impact of JWC on inflammation within the gastric mucosa of mice infected with\n                      <jats:italic>H. pylori<\/jats:italic>\n                      . Metagenomic sequencing technology was used to identify alterations in the intestinal microbiota and antibiotic resistance genes in the murine models. Western blotting was used to assess the expression levels of proteins involved in the mitogen-activated protein kinase (MAPK) signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      JWC mitigated gastric mucosal inflammation induced by\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection and reduced the concentrations of interleukin- (IL-) 6, IL-1\u03b2, and tumor necrosis factor-\u03b1 (TNF-\u03b1) while inhibiting gene expression level. Metagenomic sequencing revealed that triple therapy in Western medicine markedly diminished the diversity of the intestinal microbiota while elevating the abundance of antibiotic-resistance genes, including\n                      <jats:italic>macB<\/jats:italic>\n                      ,\n                      <jats:italic>arlR<\/jats:italic>\n                      ,\n                      <jats:italic>evgS<\/jats:italic>\n                      ,\n                      <jats:italic>tetA(58)<\/jats:italic>\n                      , and\n                      <jats:italic>mtrA<\/jats:italic>\n                      . The diversity and richness of the intestinal microbiota in the JWC group were comparable to those in the control group, with an increase in the abundance of beneficial bacteria such as\n                      <jats:italic>Muribaculaceae_bacterium<\/jats:italic>\n                      . Furthermore, the expression levels of the antibiotic resistance genes\n                      <jats:italic>macB<\/jats:italic>\n                      ,\n                      <jats:italic>tetA(58)<\/jats:italic>\n                      ,\n                      <jats:italic>bcrA<\/jats:italic>\n                      ,\n                      <jats:italic>oleC<\/jats:italic>\n                      ,\n                      <jats:italic>and arlS<\/jats:italic>\n                      were downregulated. Moreover, the activation of MAPK signaling pathway components phospho-ERK and phospho-p38 was inhibited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      JWC preserves microbial diversity and promotes a beneficial compositional shift, mitigates the risk of antibiotic resistance, modulates the MAPK signaling pathway, and alleviates gastric mucosal inflammation in mice infected with\n                      <jats:italic>H. pylori<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1628594","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:29:03Z","timestamp":1764311343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Jinghuaweikang capsule alleviates Helicobacter pylori-infected gastric mucosal inflammation and drug resistance by regulating intestinal microbiota and MAPK pathway"],"prefix":"10.3389","volume":"15","author":[{"given":"Yao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Miao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020319","article-title":"Butyric acid supplementation reduces changes in\u00a0the taxonomic and functional composition of gut microbiota caused by\u00a0H","volume":"12","author":"Abdulkhakov","year":"2024","journal-title":"pylori Eradication Ther. Microorganisms."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer - a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1909459","article-title":"The interplay between Helicobacter pylori and gastrointestinal microbiota","volume":"13","author":"Chen","year":"2021","journal-title":"Gut\u00a0Microbes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1066244","article-title":"Fuzheng Nizeng Decoction regulated ferroptosis and endoplasmic reticulum stress in the treatment of gastric precancerous lesions: A mechanistic study based on metabolomics coupled with transcriptomics","volume":"13","author":"Chu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrendo.2014.210","article-title":"Antibiotics in early life and obesity","volume":"11","author":"Cox","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12866-022-02732-6","article-title":"The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000527047","article-title":"Effects of helicobacter pylori therapy on gut microbiota: A systematic review and meta-analysis","volume":"42","author":"Du","year":"2024","journal-title":"Dig Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.micinf.2007.03.004","article-title":"In-Cell Western analysis of Helicobacter pylori-induced phosphorylation of extracellular-signal related kinase via the transactivation of the epidermal growth factor receptor","volume":"9","author":"Du","year":"2007","journal-title":"Microbes Infect."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117793","article-title":"Treatment of gastric ulcer, traditional Chinese medicine may be a better choice","volume":"324","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3969\/j.issn.1008-7125.2022.05.006","article-title":"Sixth chinese national consensus report on management of helicobacter pylori infection(Treatment excluded)","volume":"27","author":"Zhou","year":"2022","journal-title":"Chin. J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3760\/cma.j.cn311367-20220929-00479","article-title":"Chinese Society of Gastroenterology, Chinese Medical Association. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment","volume":"42","year":"2022","journal-title":"Chin. J. Dig"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.cgh.2023.02.026","article-title":"Helicobacter pylori antimicrobial resistance in a pediatric population from the new england region of the United States","volume":"21","author":"Herzlinger","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Asian Pacific Alliance on Helicobacter and Microbiota. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000500634","article-title":"Influence of helicobacter pylori infection and atrophic gastritis on the gut microbiota in a Japanese population","volume":"101","author":"Iino","year":"2020","journal-title":"Digestion"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.24976\/Discov.Med.202436188.171","article-title":"Characterization of metronidazole, clarithromycin and amoxicillin resistance genes in helicobacter pylori isolated from gastroenteritis patients","volume":"36","author":"Iqbal","year":"2024","journal-title":"Discov. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJM199911253412203","article-title":"Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals","volume":"341","author":"Johnson","year":"1999","journal-title":"N Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.4049\/jimmunol.163.10.5552","article-title":"Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori","volume":"163","author":"Keates","year":"1999","journal-title":"J. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"48127","DOI":"10.1074\/jbc.M107630200","article-title":"cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells","volume":"276","author":"Keates","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.celrep.2016.01.017","article-title":"Gastric helicobacter pylori infection affects local and distant microbial populations and host responses","volume":"14","author":"Kienesberger","year":"2016","journal-title":"Cell Rep."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10091099","article-title":"Helicobacter pylori-induced inflammation: possible factors modulating the risk of gastric cancer","volume":"10","author":"Kumar","year":"2021","journal-title":"Pathogens"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3748\/wjg.v30.i24.3086","article-title":"Effect and mechanism of Qingre Huashi decoction on drug-resistant Helicobacter pylori","volume":"30","author":"Lin","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S2468-1253(22)00384-3","article-title":"Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial","volume":"8","author":"Liou","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050593","article-title":"Efficacy and long-term safety of H. pylori eradication for gastric cancer prevention","volume":"11","author":"Liou","year":"2019","journal-title":"Cancers (Basel)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/jgh.14992","article-title":"Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota","volume":"35","author":"Liou","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B28","volume-title":"Effects and mechanism of Jinghua Weikang capsule and its decoction on drug-resistant Helicobacter pylori","author":"Liu","year":"2014"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020441","article-title":"Comparison of the effects between tannins extracted from different natural plants on growth performance, antioxidant capacity, immunity, and intestinal flora of broiler chickens","volume":"12","author":"Liu","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","author":"Lynch","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8513","DOI":"10.1128\/MCB.20.22.8513-8525.2000","article-title":"The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase","volume":"20","author":"Maroun","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2108655","article-title":"The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management","volume":"14","author":"Nabavi-Rad","year":"2022","journal-title":"Gut Microbes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2468-1253(20)30267-3","article-title":"Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden","volume":"5","author":"Nguyen","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4162\/nrp.2017.11.1.11","article-title":"Anti-bacterial effects of enzymatically-isolated sialic acid from glycomacropeptide in a Helicobacter pylori-infected murine model","volume":"11","author":"Noh","year":"2017","journal-title":"Nutr. Res. Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/hel.13028","article-title":"Antimicrobial-resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018-2020","volume":"29","author":"Okimoto","year":"2024","journal-title":"Helicobacter"},{"key":"B38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1142\/S0192415X22500203","article-title":"Atractylodes lancea rhizoma attenuates DSS-induced colitis by regulating intestinal flora and metabolites","volume":"50","author":"Qu","year":"2022","journal-title":"Am. J. Chin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1083\/jcb.149.7.1419","article-title":"Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses","volume":"149","author":"Schaeper","year":"2000","journal-title":"J. Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/152165401317190833","article-title":"Role of ERK and p38 mitogen-activated protein kinase cascades in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide","volume":"51","author":"Slomiany","year":"2001","journal-title":"IUBMB Life."},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0006-291X(02)00463-1","article-title":"Disruption in gastric mucin synthesis by Helicobacter pylori lipopolysaccharide involves ERK and p38 mitogen-activated protein kinase participation","volume":"294","author":"Slomiany","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.14744\/ejmo.2023.33713","article-title":"Linked color imaging and color analytic model based on pixel brightness for diagnosing H. Pylori infection in gastric antrum","volume":"7","author":"Sun","year":"2023","journal-title":"Eurasian J. Med. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10.1128","DOI":"10.1128\/microbiolspec.ARBA-0032-2018","article-title":"Antimicrobial Resistance in Enterococcus spp. of animal origin","volume":"6","author":"Torres","year":"2018","journal-title":"Microbiol. Spectr"},{"key":"B44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MEG.0000000000000774","article-title":"Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis","volume":"29","author":"Upala","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jgar.2023.05.014","article-title":"Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis","volume":"34","author":"Wang","year":"2023","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117294","article-title":"Integration of gut microbiome and serum metabolome revealed the effect of Qing-Wei-Zhi-Tong Micro-pills on gastric ulcer in rats","volume":"319","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1134369","article-title":"Integrating microbiome and metabolome revealed microbe-metabolism interactions in the stomach of patients with different severity of peptic ulcer disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3760\/cma.j.issn.0376-2491.2013.44.002","article-title":"Jinghuaweikang gelatin pearls plus proton pump inhibitor-based triple regimen in the treatment otchronic atrophic gastritis with Helicobacter pylori infection: a multicenter. randomized, controlled clinical study","volume":"93","author":"Wang","year":"2013","journal-title":"Natl. Med. J. China."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e13038","DOI":"10.1111\/hel.13038","article-title":"Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023","volume":"29","author":"Xu","year":"2024","journal-title":"Helicobacter"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/insects16090970","article-title":"Response of nutritional values and gut microbiomes to dietary intake of \u03c9-3 polyunsaturated fatty acids in tenebrio molitor larvae","volume":"16","author":"Yang","year":"2025","journal-title":"Insects"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-5709.2015.03.013","article-title":"The establishment of animal model by Helicobacter pylori infected Kunming mice","volume":"24","author":"Ye","year":"2015","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e12713","DOI":"10.1111\/hel.12713","article-title":"Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis","volume":"25","author":"Ye","year":"2020","journal-title":"Helicobacter"},{"key":"B53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3969\/j.issn.1671-038X.2013.11.008","article-title":"Jinghuaweikang Capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis: a multicenter, randomized, controlled clinical study","volume":"21","author":"Zhang","year":"2013","journal-title":"Chin. J. Integrated Traditional Western Med. Digestion."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.7661\/j.cjim.20200904.334","article-title":"Effect of Chenopodium ambrosioides L. @ on Biofilm Formation of Helicobacter pylori in Vitro","volume":"40","author":"Zhang","year":"2020","journal-title":"Chin. J. Integrated Traditional Western Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1628594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:29:08Z","timestamp":1764311348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1628594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":55,"alternative-id":["10.3389\/fcimb.2025.1628594"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1628594","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1628594"}}